[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100548797":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":35,"locations":40,"responsibleParty":116,"collaborators":119,"id":125,"slug":126,"hasResults":127,"nctId":128,"briefTitle":129,"officialTitle":130,"acronym":131,"eligibilityCriteria":132,"healthyVolunteers":127,"sex":133,"minAge":134,"maxAge":25,"enrollmentInfo":135,"targetDuration":25,"studyType":138,"phases":139,"briefSummary":141,"conditions":142,"keywords":145,"overallStatus":64,"whyStopped":25,"lastUpdateSubmitDate":151,"lastUpdatePostDateStruct":152,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":160},{"fullName":5,"class":6},"University of Cologne","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Experimental intervention \u002Farm 1","EXPERIMENTAL","After randomisation the investigational therapy (arm 1), patients undergo a cataract surgery with preservation of the diseased endothelial cells. The cataract surgery will take approximately 10-20 minutes.\n\nThe follow-up period after surgery will be 22 weeks ± 14 days.",[13],"Procedure: Intervention group \u002Farm 1 (Cataract surgery alone)",{"label":15,"type":6,"description":16,"interventionNames":17},"Control intervention \u002Farm2","After randomisation, patients in the comparator therapy (arm 2) undergo triple-DMEK which is a cataract surgery combined with DMEK (removal of the diseased endothelial cells followed by transplantation of a healthy endothelial cell layer).\n\nTriple-DMEK takes approximately 5-10 minutes longer than cataract surgery. The follow-up period after surgery will be 22 weeks ± 14 days.",[18],"Procedure: Control group \u002Farm 2: Corneal transplantation as Descemet Membrane Endothelial Keratoplasty (DMEK) in combination with cataract surgery (triple-DMEK)",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"PROCEDURE","Intervention group \u002Farm 1 (Cataract surgery alone)","Cataract surgery (arm 1) is performed using a small incision technique. The tunnel is used both for cataract surgery and for implantation of the DMEK graft (arm 2). The centres confirmed that the main incision will be localized between 11 and 12 o'clock and will have a width of 2.4 to 2.8 mm. A tunnel suture will only be placed if there is leakage from the incisions. If cataract surgery alone (arm 1) is performed, a thin dispersive viscoelastic is applied to the endothelium for protection before phacoemulsification. A hydrophobic acrylic monofocal IOL will be implanted into the bag. The centers confirmed that Barret Universal II formula is the standard IOL calculation formula for both groups and for all axial lengths.",[9],null,{"type":21,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Control group \u002Farm 2: Corneal transplantation as Descemet Membrane Endothelial Keratoplasty (DMEK) in combination with cataract surgery (triple-DMEK)","After cataract surgery DMEK is continued using the surgeon's standard technique for graft implantation and unfolding in triple-DMEK. In all cases the graft will be implanted using the same main incision as for IOL implantation. Once the DMEK graft is unrolled and attached to the posterior corneal stroma the complete anterior chamber will be filled with SF6 20%.",[15],[31],{"name":32,"affiliation":33,"role":34},"Björn Bachmann, Prof.","University Hospital Cologne","PRINCIPAL_INVESTIGATOR",[36],{"name":32,"role":37,"phone":38,"phoneExt":25,"email":39},"CONTACT","0049-221 478-87476","bjoern.bachmann@uk-koeln.de",[41,62,79,98],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Department of Ophthalmology, Aarhus University Hospital","NOT_YET_RECRUITING","Aarhus N","Central Jutland","DK- 8200","Denmark","DK",{"type":50,"coordinates":51},"Point",[52,53],10.17317,56.20367,{"lat":53,"lon":52},[56,61],{"name":57,"role":37,"phone":58,"phoneExt":59,"email":60},"Jesper Hjortdal, Prof.","78 45 46 44, 23346770","0045","jesper.hjortdal@clin.au.dk",{"name":57,"role":34,"phone":25,"phoneExt":25,"email":25},{"facility":63,"status":64,"city":65,"state":66,"zip":67,"country":68,"countryCode":69,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Klinik für Ophthalmologie des Universitätsklinikums Köln","RECRUITING","Cologne","North Rhine-Westphalia","50937","Germany","DE",{"type":50,"coordinates":71},[72,73],6.95,50.93333,{"lat":73,"lon":72},[76,78],{"name":32,"role":37,"phone":77,"phoneExt":25,"email":39},"0049-2214784308",{"name":32,"role":34,"phone":25,"phoneExt":25,"email":25},{"facility":80,"status":43,"city":81,"state":82,"zip":83,"country":84,"countryCode":85,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Radboud-Universität Nijmegen","Nijmegen","Gelderland","GA 6525","Netherlands","NL",{"type":50,"coordinates":87},[88,89],5.85278,51.8425,{"lat":89,"lon":88},[92,97],{"name":93,"role":37,"phone":94,"phoneExt":95,"email":96},"Siamak Nobacht, Dr.","653613048","0031","Siamak.Nobacht@radboudumc.nl",{"name":93,"role":34,"phone":25,"phoneExt":25,"email":25},{"facility":99,"status":43,"city":100,"state":100,"zip":101,"country":102,"countryCode":103,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Instituto de microcirugía ocular; Departamento de Cornea y Cirugia Refractiva","Barcelona","08035","Spain","ES",{"type":50,"coordinates":105},[106,107],2.15899,41.38879,{"lat":107,"lon":106},[110,115],{"name":111,"role":37,"phone":112,"phoneExt":113,"email":114},"José Luis Güell, Dr.","934 000 700","0034","Jose.guell@imo.es",{"name":111,"role":34,"phone":25,"phoneExt":25,"email":25},{"type":34,"investigatorFullName":117,"investigatorTitle":118,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Björn Bachmann","Clinical Professor",[120,122],{"name":121,"class":6},"The Clinical Trials Centre Cologne",{"name":123,"class":124},"ESCRS (European Society of Cataract and Refractive Surgeons)","UNKNOWN","100548797","trial-comparing-cataract-surgery-with-triple-dmek-in-patients-with-cataract-and-fuchs-endothelial-corneal-dystrophy-100548797",false,"NCT06425666","Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy","European Prospective Multicentre Trial Comparing Cataract Surgery With Triple-DMEK in Patients With Cataract and Fuchs Endothelial Corneal Dystrophy (ETCF-trial)","ETCF","Inclusion Criteria:\n\n1. Patients with FECD and nuclear cataract in study eye\n2. Male and female patients ≥18 years of age\n3. Subject must be able to understand and read the national language.\n4. Written informed consent prior to any study-related procedures\n5. Nuclear opalescence (NO) grades 2 and 3 according to the lens opacities classification system III (LOCS III)\n6. Krachmer grade (3 \\[2-5 mm diameter area with confluent guttae\\]; 4 \\[ \\> 5 mm diameter area with confluent guttae\\] without edema identified by slit lamp examination)\n7. Central corneal thickness (CCT) measured with Pentacam below 620 µm between 8:00 am and 01:00 pm\n8. BCVA logMAR \\\u003C 0,7 and \\> 0,1\n9. No previous cataract surgery or triple-DMEK on the opposite side\n10. Pentacam quality specification: \"OK\"\n11. For women below age of 60 negative urine pregnancy test\n\nExclusion Criteria:\n\n1. Patients with ocular and\u002For systemic comorbidity affecting vision or clinically proven anterior and\u002For posterior segment disease other than FECD and cataract (exclusion of macular disease or edema by OCT)\n2. Iris synechiae, pupil diameter \\\u003C6 mm after dilatation, pseudoexfoliation syndrome, subluxated lens, previous history of ocular trauma\u002Fsurgery or inflammatory disease\n3. Subjective diurnal changes in visual acuity with worse visual acuity in the morning\n4. Corneal (epithelial) edema visible at slit lamp examination\n5. Preoperative anterior chamber depth below 2 mm\n6. Participation in other interventional trials parallel or within the last 4 weeks\n7. Systemic use of Alpha-1-Adrenozeptor-Antagonists, immunosuppressive therapy or chemotherapy\n8. Pregnant women and nursing mothers\n9. Persons with any kind of dependency on the principal investigator or employed by the sponsor or principal investigator\n10. Legally incapacitated persons\n11. Persons held in an institution by legal or official order","ALL","18 Years",{"count":136,"type":137},120,"ESTIMATED","INTERVENTIONAL",[140],"NA","The purpose of the study is to investigate whether there is a difference in BCVA in patients who receive one of the following two surgeries: intervention group (arm 1) cataract surgery alone and control group (arm 2) cataract surgery combined with removal of the diseased endothelial cells and the attached Descemet's membrane followed by transplantation of a healthy endothelial cell layer with attached Descemet's membrane (\"triple-DMEK\" group; comparator therapy).\n\nThe secondary objectives are to compare the two surgical methods with regard to other visual functions and optical as well as morphological differences, to safety, to quality of life, and to safety.",[143,144],"Cataract Surgery","Cataract and Fuchs Endothelial Corneal Dystrophy",[146,147,148,149,150],"Fuchs´ Endothelial Corneal Dystrophy Krachmer grade 3 and 4","nuclear cataract","Nuclear opalescence (NO) grades 2","Nuclear opalescence (NO) grades 3","Central corneal thickness","2025-02-19",{"date":153,"type":154},"2025-02-21","ACTUAL",{"date":156,"type":154},"2025-01-24",{"date":158,"type":137},"2026-06",{"name":5,"class":6},4]